相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments
Xiaoling Jiang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML
Michael E. Vinyard et al.
NATURE CHEMICAL BIOLOGY (2019)
Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation
Jade D. Bailey et al.
CELL REPORTS (2019)
Anti-tumor effect of sulfasalazine in neuroblastoma
Marie R. Mooney et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
Fang Huang et al.
CELL METABOLISM (2018)
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
Ken-ichi Takayama et al.
ONCOGENE (2018)
Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia
Alba Maiques-Diaz et al.
CELL REPORTS (2018)
The metabolite BH4 controls T cell proliferation in autoimmunity and cancer
Shane J. F. Cronin et al.
NATURE (2018)
Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity
D. Zhang et al.
ONCOGENE (2017)
BH3-only protein BIM: An emerging target in chemotherapy
Shatrunajay Shukla et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2017)
DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells
Hongyang Li et al.
CELL DEATH & DISEASE (2017)
mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability
Alexander J. Valvezan et al.
CANCER CELL (2017)
DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment
Hongzhi Du et al.
ONCOLOGY REPORTS (2016)
Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target
Lisette P. Yco et al.
BMC CANCER (2015)
Reduction of Neuropathic and Inflammatory Pain through Inhibition of the Tetrahydrobiopterin Pathway
Alban Latremoliere et al.
NEURON (2015)
Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells
Xiangxuan Zhao et al.
PROTEIN & CELL (2015)
Sulfa Drugs Inhibit Sepiapterin Reduction and Chemical Redox Cycling by Sepiapterin Reductase
Shaojun Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation
Ingo Lange et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells
S. Carbajo-Pescador et al.
BRITISH JOURNAL OF CANCER (2013)
Alkylglycerol monooxygenase
Katrin Watschinger et al.
IUBMB LIFE (2013)
Sepiapterin Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells
Shaojun Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Tetrahydrobiopterin Biosynthesis as an Off-Target of Sulfa Drugs
Hirohito Haruki et al.
SCIENCE (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia
Thomas Opladen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Tetrahydrobiopterin: biochemistry and pathophysiology
Ernst R. Werner et al.
BIOCHEMICAL JOURNAL (2011)
Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia
Yong-Kee Choi et al.
BMB Reports (2011)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang et al.
NATURE (2011)
A yeast-based screen reveals that sulfasalazine inhibits tetrahydrobiopterin biosynthesis
Christopher Chidley et al.
NATURE CHEMICAL BIOLOGY (2011)
Runx1 Is a Co-activator with FOXO3 to Mediate Transforming Growth Factor β (TGFβ)-induced Bim Transcription in Hepatic Cells
Gary M. Wildey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase
Beat Thoeny et al.
HUMAN MUTATION (2006)
Tetrahydrobiopterin deficiencies without hyperphenylalaninemia:: Diagnosis and genetics of DOPA-responsive dystonia and sepiapterin reductase deficiency
N Blau et al.
MOLECULAR GENETICS AND METABOLISM (2001)
分享论文
